Excessive adipose depots and sarcopenia are associated with poor prognosis and mortality in several chronic conditions including chronic obstructive pulmonary disease (COPD) (1,2). Obesity is associated with lower mortality in patients with COPD, referred to as the obesity paradox (3). Sarcopenia is the clinical syndrome of diminished muscle mass and strength and has an estimated prevalence of 22% in patients with COPD (2,4). In contradistinction to obesity, sarcopenia is associated with higher risks of mortality in COPD and impaired functional status (4,5).CT is the reference standard for the quantitative study of adipose depots (including the subcutaneous adipose tissue [SAT] and intermuscular adipose tissue [IMAT]).Background: Obesity and sarcopenia are associated with mortality in chronic obstructive pulmonary disease (COPD). Routine chest CT examinations may allow assessment of obesity and sarcopenia by soft-tissue markers for predicting risks of mortality.Purpose: To investigate associations between soft-tissue markers subcutaneous adipose tissue (SAT), intermuscular adipose tissue (IMAT), and pectoralis muscle (PM) index from chest CT with mortality in participants with COPD.
Materials and Methods:In this secondary analysis of a prospectively enrolled cohort from the Multi-Ethnic Study of Atherosclerosis, participants with available chest CT in 2010-2012 were included. CT examinations were analyzed to determine SAT, IMAT (within PM), and PM areas. The spirometry evaluations were used to establish COPD diagnosis. Mortality data were extracted from the National Death Index (April 2010 to December 2017). The correlations of the soft-tissue markers with fat mass index were studied. The associations of these markers and risks of mortality in participants with COPD were assessed by using Cox proportional-hazard models adjusted for confounders.Results: Among 2994 participants who were included (mean age, 69 years 9 [standard deviation]; 1551 women), 265 had COPD (9%; mean age, 72 years 9; 162 men) and 49 participants with COPD (18%) died during follow-up. The SAT, IMAT, and PM areas had moderate-to-excellent reliabilities (intraclass correlation coefficient, 0.88-0.99). In the 2994 participants, the SAT ( = 0.80; 95% CI: 0.78, 0.81; P .001) and IMAT indexes ( = 0.37; 95% CI: 0.34, 0.41; P .001) were correlated with fat mass index. Those with COPD and higher SAT index had lower risks of mortality (hazard ratio, 0.2; 95% CI: 0.1, 0.4; P .001, per doubling), whereas a higher IMAT index was associated with a higher risk of mortality (hazard ratio, 1.4; 95% CI: 1.0, 1.9; P = .04, per doubling).
Conclusion:Soft-tissue markers were reliably obtained by using chest CT performed for lung assessment. In participants with chronic obstructive pulmonary disease, a high intermuscular adipose tissue index was associated with a higher risk of mortality than was a high subcutaneous adipose tissue index.